The Effect of Cultivation Passaging on the Relative Telomere Length and Proliferation Capacity of Dental Pulp Stem Cells
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Telomere Length Shortening in Microglia: Implication for Accelerated Senescence and Neurocognitive Deficits in HIV
Article Telomere Length Shortening in Microglia: Implication for Accelerated Senescence and Neurocognitive Deficits in HIV Chiu-Bin Hsiao 1, Harneet Bedi 2, Raquel Gomez 2, Ayesha Khan 2, Taylor Meciszewski 2, Ravikumar Aalinkeel 2, Ting Chean Khoo 3, Anna V. Sharikova 3, Alexander Khmaladze 3 and Supriya D. Mahajan 2,* 1 Medicine Institute, School of Medicine, Infectious Diseases, Drexel University, Positive Health Clinic, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, PA 15212, USA; [email protected] 2 Department of Medicine, Division of Allergy, Immunology & Rheumatology, University at Buffalo’s Clinical Translational Research Center, Buffalo, NY 14203, USA; [email protected] (H.B.); [email protected] (R.G.); [email protected] (A.K.); [email protected] (T.M.); [email protected] (R.A.) 3 Department of Physics, University at Albany SUNY, Albany, NY 12222, USA; [email protected] (T.C.K.); [email protected] (A.V.S.); [email protected] (A.K.) * Correspondence: [email protected]; Tel.: +1-1-716-888-4776 Abstract: The widespread use of combination antiretroviral therapy (cART) has led to the accelerated aging of the HIV-infected population, and these patients continue to have a range of mild to moderate HIV-associated neurocognitive disorders (HAND). Infection results in altered mitochondrial function. The HIV-1 viral protein Tat significantly alters mtDNA content and enhances oxidative stress in immune cells. Microglia are the immune cells of the central nervous system (CNS) that exhibit Citation: Hsiao, C.-B.; Bedi, H.; a significant mitotic potential and are thus susceptible to telomere shortening. HIV disrupts the Gomez, R.; Khan, A.; Meciszewski, T.; normal interplay between microglia and neurons, thereby inducing neurodegeneration. -
Fructose Causes Liver Damage, Polyploidy, and Dysplasia in the Setting of Short Telomeres and P53 Loss
H OH metabolites OH Article Fructose Causes Liver Damage, Polyploidy, and Dysplasia in the Setting of Short Telomeres and p53 Loss Christopher Chronowski 1, Viktor Akhanov 1, Doug Chan 2, Andre Catic 1,2 , Milton Finegold 3 and Ergün Sahin 1,4,* 1 Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA; [email protected] (C.C.); [email protected] (V.A.); [email protected] (A.C.) 2 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; [email protected] 3 Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA; fi[email protected] 4 Department of Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA * Correspondence: [email protected]; Tel.: +1-713-798-6685; Fax: +1-713-798-4146 Abstract: Studies in humans and model systems have established an important role of short telomeres in predisposing to liver fibrosis through pathways that are incompletely understood. Recent studies have shown that telomere dysfunction impairs cellular metabolism, but whether and how these metabolic alterations contribute to liver fibrosis is not well understood. Here, we investigated whether short telomeres change the hepatic response to metabolic stress induced by fructose, a sugar that is highly implicated in non-alcoholic fatty liver disease. We find that telomere shortening in telomerase knockout mice (TKO) imparts a pronounced susceptibility to fructose as reflected in the activation of p53, increased apoptosis, and senescence, despite lower hepatic fat accumulation in TKO mice compared to wild type mice with long telomeres. The decreased fat accumulation in TKO Citation: Chronowski, C.; Akhanov, is mediated by p53 and deletion of p53 normalizes hepatic fat content but also causes polyploidy, V.; Chan, D.; Catic, A.; Finegold, M.; Sahin, E. -
Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant
Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children’s Research Hospital Departments of Hematology, Patient Education, and Biomedical Communications. Funds were provided by St. Jude Children’s Research Hospital, ALSAC, and a grant from the Plough Foundation. This document is not intended to take the place of the care and attention of your personal physician. Our goal is to promote active participation in your care and treatment by providing information and education. Questions about individual health concerns or specifi c treatment options should be discussed with your physician. For more general information on sickle cell disease, please visit our Web site at www.stjude.org/sicklecell. Copyright © 2009 St. Jude Children’s Research Hospital How did bone marrow (stem cell) transplants begin for children with sickle cell disease? Bone marrow (stem cell) transplants have been used for the treatment and cure of a variety of cancers, immune system diseases, and blood diseases for many years. Doctors in the United States and other countries have developed studies to treat children who have severe sickle cell disease with bone marrow (stem cell) transplants. How does a bone marrow (stem cell) transplant work? 2 In a person with sickle cell disease, the bone marrow produces red blood cells that contain hemoglobin S. This leads to the complications of sickle cell disease. • To prepare for a bone marrow (stem cell) transplant, strong medicines, called chemotherapy, are used to weaken or destroy the patient’s own bone marrow, stem cells, and infection fi ghting system. -
Genetic Manipulation of Stem Cells Eleni Papanikolaou1,2*, Kalliopi I
logy & Ob o st ec e tr n i y c s G Papanikolaou et al. Gynecol Obstetric 2011, S:6 Gynecology & Obstetrics DOI: 10.4172/2161-0932.S6-001 ISSN: 2161-0932 Review Article Open Access Genetic Manipulation of Stem Cells Eleni Papanikolaou1,2*, Kalliopi I. Pappa1,3 and Nicholas P. Anagnou1,2 1Laboratory of Cell and Gene Therapy, Centre for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece 2Laboratory of Biology, University of Athens School of Medicine, Athens, Greece 3First Department of Obstetrics and Gynecology, University of Athens School of Medicine, Alexandra Hospital, Athens, Greece Abstract Stem cells have the remarkable potential for self-renewal and differentiation into many cell types in the body during early life and development. In addition, in many tissues they constitute a source of internal repair system, dividing essentially without limit to replenish damaged or dead cells. After division, each new cell has the potential either to retain the stem cell status or to differentiate to a more specialized cell type, such as a red blood cell, a brain cell or a heart cell. Until recently, three types of stem cells from animals and humans have been characterized, i.e. embryonic stem cells, fetal stem cells and somatic adult stem cells. However, in late 2007, researchers accomplished another breakthrough by identifying conditions that allow some specialized adult cells to be “reprogrammed” genetically to assume a stem cell-like state. These cells, called induced pluripotent stem cells (iPSCs), express genes and factors important for maintaining the unique properties and features of embryonic stem cells. -
Genetics and Stem Cell Research A.Genetics
7: Genetics and Stem Cell Research A.Genetics 1. Introduction The principal special feature of genetics research is that the result of the study applies not only to the proband but also influences her lineage both in the past and in the future. For example genetic studies demonstrated Thomas Jefferson’s sexual relationship with his slave Sally Hemings and defined their descendants to this day. As we all know from television, genetic studies can be done from any tissue fragment that contains DNA so that studies of surgical specimens, biopsy materials, hair, epithelium and blood samples can all be utilized for extensive genetic studies. 2. Sampling Some DNA is more medically valuable than other. Samples from isolated populations in which a particular disorder is prevalent have a much greater probability of yielding the causal gene(s) because they have fewer genome variations than in the general population. Once isolated, the genetic material associated with the disorder has a good chance of yielding novel diagnostic and/or therapeutic approaches for the disorder. 3. Property rights A persistent question is whether the providers of the genetic material have any rights to the products created from their genetic material. These days, most consent forms are written explicitly to exclude intellectual property rights from the subjects. As might be imagined, this smacks of exploitation in the developing world. Negotiation of a monetary return to the community has sometimes been concluded. Important and lucrative products have been derived from individuals’ genomes without their receiving royalties or other compensation. However, the knowledge, technical expertise, and capital needed to make a useful product from a blood or tissue sample come from the company not the donor. -
The Amazing Stem Cell What Are They? Where Do They Come From? How Are They Changing Medicine? Stem Cells Are “Master Cells”
The Amazing Stem Cell What are they? Where do they come from? How are they changing medicine? Stem cells are “master cells” Stem cells can be “guided” to become many other cell types. Stem Cell Bone cell Self-renewed stem cell Brain cell Heart muscle Blood cell cell There are several types of stem cells, each from a unique source Embryonic stem cells* • Removed from embryos created for in vitro fertilization after donation consent is given. (Not sourced from aborted fetuses.) • Embryos are 3-5 days old (blastocyst) and have about 150 cells. • Can become any type of cell in the body, also called pluripotent cells. • Can regenerate or repair diseased tissue and organs. • Current use limited to eye-related disorders. * Not used by Mayo Clinic. Adult stem cells • Found in most adult organs and tissues, including bone marrow. • Often taken from bone marrow in the hip. • Blood stem cells can be collected through apheresis (separated from blood). • Can regenerate and repair diseased or damaged tissues (regenerative medicine). • Can be used as specialized “drugs” to potentially treat degenerative conditions. • Currently tested in people with neurological and heart disease. Umbilical cord blood stem cells • Found in blood in placenta and umbilical cord after childbirth. • Have the ability to change into specialized cells (like blood cells), also called progenitor cells. • Parents choose to donate umbilical cord blood for use in research, or have it stored for private or public banks. • Can be used in place of bone marrow stem cell transplants in some clinical applications. Bioengineered stem cells • Regular adult cells (e.g., blood, skin) reprogrammed to act like embryonic stem cells (induced pluripotent stem cells). -
The Longest Telomeres: a General Signature of Adult Stem Cell Compartments
Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press The longest telomeres: a general signature of adult stem cell compartments Ignacio Flores,1 Andres Canela,1 Elsa Vera,1 Agueda Tejera,1 George Cotsarelis,2 and María A. Blasco1,3 1Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid E-28029, Spain; 2University of Pennsylvania School of Medicine, M8 Stellar-Chance Laboratories, Philadelphia, Pennsylvania 19104, USA Identification of adult stem cells and their location (niches) is of great relevance for regenerative medicine. However, stem cell niches are still poorly defined in most adult tissues. Here, we show that the longest telomeres are a general feature of adult stem cell compartments. Using confocal telomere quantitative fluorescence in situ hybridization (telomapping), we find gradients of telomere length within tissues, with the longest telomeres mapping to the known stem cell compartments. In mouse hair follicles, we show that cells with the longest telomeres map to the known stem cell compartments, colocalize with stem cell markers, and behave as stem cells upon treatment with mitogenic stimuli. Using K15-EGFP reporter mice, which mark hair follicle stem cells, we show that GFP-positive cells have the longest telomeres. The stem cell compartments in small intestine, testis, cornea, and brain of the mouse are also enriched in cells with the longest telomeres. This constitutes the description of a novel general property of adult stem cell compartments. Finally, we make the novel finding that telomeres shorten with age in different mouse stem cell compartments, which parallels a decline in stem cell functionality, suggesting that telomere loss may contribute to stem cell dysfunction with age. -
Telomere-To-Telomere Assembly of a Complete Human X Chromosome W
https://doi.org/10.1038/s41586-020-2547-7 Accelerated Article Preview Telomere-to-telomere assembly of a W complete human X chromosome E VI Received: 30 July 2019 Karen H. Miga, Sergey Koren, Arang Rhie, Mitchell R. Vollger, Ariel Gershman, Andrey Bzikadze, Shelise Brooks, Edmund Howe, David Porubsky, GlennisE A. Logsdon, Accepted: 29 May 2020 Valerie A. Schneider, Tamara Potapova, Jonathan Wood, William Chow, Joel Armstrong, Accelerated Article Preview Published Jeanne Fredrickson, Evgenia Pak, Kristof Tigyi, Milinn Kremitzki,R Christopher Markovic, online 14 July 2020 Valerie Maduro, Amalia Dutra, Gerard G. Bouffard, Alexander M. Chang, Nancy F. Hansen, Amy B. Wilfert, Françoise Thibaud-Nissen, Anthony D. Schmitt,P Jon-Matthew Belton, Cite this article as: Miga, K. H. et al. Siddarth Selvaraj, Megan Y. Dennis, Daniela C. Soto, Ruta Sahasrabudhe, Gulhan Kaya, Telomere-to-telomere assembly of a com- Josh Quick, Nicholas J. Loman, Nadine Holmes, Matthew Loose, Urvashi Surti, plete human X chromosome. Nature Rosa ana Risques, Tina A. Graves Lindsay, RobertE Fulton, Ira Hall, Benedict Paten, https://doi.org/10.1038/s41586-020-2547-7 Kerstin Howe, Winston Timp, Alice Young, James C. Mullikin, Pavel A. Pevzner, (2020). Jennifer L. Gerton, Beth A. Sullivan, EvanL E. Eichler & Adam M. Phillippy C This is a PDF fle of a peer-reviewedI paper that has been accepted for publication. Although unedited, the Tcontent has been subjected to preliminary formatting. Nature is providing this early version of the typeset paper as a service to our authors and readers. The text andR fgures will undergo copyediting and a proof review before the paper is published in its fnal form. -
Nano-Biosensor for Monitoring the Neural Differentiation of Stem Cells
nanomaterials Review Nano-Biosensor for Monitoring the Neural Differentiation of Stem Cells Jin-Ho Lee 1,2,†, Taek Lee 1,2,† and Jeong-Woo Choi 1,2,* 1 Department of Chemical and Biomolecular Engineering, Sogang University, 35 Baekbeom-ro (Sinsu-dong), Mapo-gu, Seoul 121-742, Korea; [email protected] (J.-H.L.); [email protected] (T.L.) 2 Institute of Integrated Biotechnology, Sogang University, 35 Baekbeom-ro (Sinsu-dong), Mapo-gu, Seoul 121-742, Korea * Correspondence: [email protected]; Tel.: +82-2-718-1976; Fax: +82-2-3273-0331 † These authors contributed equally to this work. Academic Editors: Chen-Zhong Li and Ling-Jie Meng Received: 6 July 2016; Accepted: 17 November 2016; Published: 28 November 2016 Abstract: In tissue engineering and regenerative medicine, monitoring the status of stem cell differentiation is crucial to verify therapeutic efficacy and optimize treatment procedures. However, traditional methods, such as cell staining and sorting, are labor-intensive and may damage the cells. Therefore, the development of noninvasive methods to monitor the differentiation status in situ is highly desirable and can be of great benefit to stem cell-based therapies. Toward this end, nanotechnology has been applied to develop highly-sensitive biosensors to noninvasively monitor the neural differentiation of stem cells. Herein, this article reviews the development of noninvasive nano-biosensor systems to monitor the neural differentiation of stem cells, mainly focusing on optical (plasmonic) and eletrochemical methods. The findings in this review suggest that novel nano-biosensors capable of monitoring stem cell differentiation are a promising type of technology that can accelerate the development of stem cell therapies, including regenerative medicine. -
BIOTECH Basics of Each Chromosome Are Repeating Sequences of DNA Known As Telomeres
What You Need to Know n DNA is organized into small structures known as chromosomes. At the ends BIOTECH Basics of each chromosome are repeating sequences of DNA known as telomeres. n Every time the cell divides and copies its DNA, the very end of the telomere is unable to be copied and the total telomere length is shortened. n Telomeres act as a buffer to protect the genes near the ends of the chro- mosome from being degraded by the Telomeres shortening process. the aglets of the genomic world n When the telomeres become too short, the cell stops dividing. This is called senescence and is associated hink about your fa- times. Telomere length varies between with aging. Tvorite pair of lace- individuals and across cell type but there up shoes. Focus on the may be as many as 15,000 nucleotides at n An enzyme known as telomerase is active in a small number of cells to keep shoelaces from those shoes, specifically the tip of a chromosome. telomeres long. Most adult cells have on the tips where the small plastic or met- When a cell divides, the chromosomes no telomerase present. al coverings wrap around the lace. Those are copied by specific enzymes and pro- coverings, known as aglets, protect the vide each daughter cell with a complete n There seems to be a link between long telomeres and longevity. Possibly ends from damage and keep the fibers set of genetic information. Unfortunately, those individuals who live long lives are of the lace from unraveling. If the aglet the copying enzymes are unable to com- producing a very low level of telom- wears away, the end becomes frayed and pletely reproduce the very end of each erase in their adult cells. -
Stem Cell Research: an Overview
Biochemistry & Molecular Biology Letters Review | Vol 3 Iss 2 Stem Cell Research: An Overview Shatadru Bhattacharjee* Department of Pharmacognosy, Dr. BC Roy College of Pharmacy, West Bengal, India *Corresponding author: Shatadru B, Dr. BC Roy College of Pharmacy, West Bengal, India, Email- [email protected] Received: March 03, 2017; Accepted: March 19, 2017; Published: March 24, 2017 Abstract A primary cell can reproduce itself or give rise to more specialized cell type is known as stem cell. The stem cell is the primogenitor at the top of the family tree among all type of cell [1-7]. One blood stem cell gives birth to red blood cells (RBC), white cells (WBC) and platelets stem cells that vary in their developmental capacity. A multi-potent stem cell can give birth to several types of mature cell. A pluripotent stem cell can give birth to all types of adult tissue cells and extra embryonic tissue cells which support embryonic development inside fetus[8-14]. A totipotent stem cell can give birth to a new individual given appropriate maternal support. The current growth of stem cell research is quiet good from last few decades. Stem cell therapy has capabilities of regenerating any human tissue damaged by injury, disease or ageing could be available within a few years. In this review there are few discussion related to current stem cell research and development [15-21]. Keywords: Stem cell; Regenerative medicine; Cell biology Introduction Stem cells have the remarkable potential in the development of several different type of cell in the body during early life and growth [22-28]. -
Basic Pluripotent Stem Cell Culture Protocols Maria Borowski∗, Maria Giovino-Doherty, Lan Ji, Meng-Jiao Shi, Kelly P
Basic pluripotent stem cell culture protocols Maria Borowski∗, Maria Giovino-Doherty, Lan Ji, Meng-Jiao Shi, Kelly P. Smith and Joseph Laning, Massachusetts Stem Cell Bank, University of Massachusetts Medical School, Shrewsbury, MA 01545 USA Abstract Stem cell research is a rapidly expanding field with the potential to develop therapeutic agents to treat diseases as well as study disease development from early stages. The culture of human pluripotent stem cells shares many of the same protocols as standard mammalian cell culture. However, the successful culture and maintenance of human pluripotent stem cells (hPSCs) in an undifferentiated state requires additional consider- ations to ensure that cells maintain their key characteristics of self-renewal and pluripotency. There are several basic techniques needed for the culturing of mammalian cells, including thawing frozen stocks, plating cells in culture vessels, changing media, passaging and cryopreservation. The protocols in this document represent a subset of the standard operating procedures used to maintain and culture stem cells at the Massachusetts Human Stem Cell Bank, and have been thoroughly testing and verified. A Stem cell culture considerations Stem cell research is a rapidly expanding field with the potential to develop therapeutic agents to treat diseases as well as study disease development from early stages. However, to fulfill this promise, researchers need to have access to standardized protocols for the development, maintenance and differentiation of these unique cells. Such “best practices” will allow comparisons of different studies and hasten the refinement of these techniques. Such standardization can be driven by resources such as StemBook and by stem cell banks.